Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

Psychedelic stocks

Ready to invest in the experimental drug industry? Consider these 7 stocks.

For many investors, the experimental psychedelics industry may be too risky to invest in. Most companies in this sector are privately held, and psychedelic stocks are often volatile penny or OTC stocks.

Aside from being risky, these stocks can also be difficult to purchase. Most stocks will require you to have a brokerage account that offers access to OTC and international stocks, like Interactive Brokers or TradeStation.

For investors willing to take the risk, the best psychedelic stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.

How to buy psychedelic stocks

Sign up with an online broker or platform to invest in one of more of these psychedelic stocks.

  1. Compare share trading platforms. Use our comparison table to narrow down top brokers by fees and bonuses.
  2. Open and fund your brokerage account. You’ll need personal and financial details, like your contact and bank information.
  3. Search for the stock you're interested in. Find the stock by name or ticker symbol, like CMPS or MMEDF.
  4. Decide on how many to buy. Some brokers will allow you to purchase fractional shares, while others require you to purchase whole shares.
  5. Choose an order type. Invest in the psychedelic stocks now with a market order or use a limit order to delay your purchase until the stock reaches your desired price.
  6. Buy the stock. Tap or click the Buy button on your brokerage account. Once you’ve invested in the experimental drug industry, track how your stock performs to decide when it’s time to sell.

Take a deeper dive into psychedelic stocks

We round up a selection of stocks in or related to the experimental drug industry, weighting the list more heavily towards popular mid- and large-cap US stocks.

1. COMPASS Pathways (CMPS)

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.

COMPASS Pathways stock opened the day at $35.77 after a previous close of $33.91. The latest price was $36.65 (25 minute delay). COMPASS Pathways is listed on the NASDAQ and employs 61 staff.

  • Market capitalization: $1,520,121,728

Back to top


2. Mind Medicine MindMed (MMEDF)

Mind Medicine (MindMed) Inc. , a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.

Mind Medicine MindMed stock opened the day at $3.70 after a previous close of $3.67. The latest price was $3.62 (25 minute delay). Mind Medicine MindMed is listed on the OTCQB and employs 22 staff.

  • Market capitalization: $940,495,104

Back to top


3. Mycotopia Therapies (TWGL)

Mycotopia Therapies Inc. provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, autism, and addictions. The company was incorporated in 2019 and is based in Aventura, Florida.

Mycotopia Therapies stock opened the day at $2.50 after a previous close of $2.70. The latest price was $2.70 (25 minute delay). Mycotopia Therapies is listed on the PINK and employs 1 staff.

  • Market capitalization: $54,932,952
  • PEG ratio: 0

Back to top


4. Numinus Wellness (NUMI)

Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health landscape. The company operates in two divisions, Salvation Botanicals and Numinus Health.

Numinus Wellness stock opened the day at C$0.89 after a previous close of C$0.88. The latest price was C$0.87 (25 minute delay). Numinus Wellness is listed on the V and has a trailing 12-month revenue of around CAD$947,969. All prices are listed in Canadian Dollars.

  • Market capitalization: $195,380,640

Back to top


5. Mindset Pharma (MSET)

Mindset Pharma Inc. operates as a neuro-pharmaceutical drug discovery and development platform company. It offers psychedelic compounds for treatment-resistant neurological and psychiatric disorders.

Mindset Pharma stock opened the day at C$0.47 after a previous close of C$0.48. The latest price was C$0.51 (25 minute delay). Mindset Pharma is listed on the CN. All prices are listed in Canadian Dollars.

  • Market capitalization: $41,163,004

Back to top


6. Cybin (CLXPF)

Cybin Inc. , a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U. S.

Cybin stock opened the day at $2.04 after a previous close of $2.07. The latest price was $2.04 (25 minute delay). Cybin is listed on the OTCQB, has a trailing 12-month revenue of around USDC$864,000 and employs 38 staff.

  • Market capitalization: $467,638,400

Back to top


7. Field Trip Health (FTRP)

Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies. Its Research division is involved in the development of psychedelic molecules and conducting research on plant-based psychedelics.

Field Trip Health stock opened the day at C$6.49 after a previous close of C$6.44. The latest price was C$7.21 (25 minute delay). Field Trip Health is listed on the CN and has a trailing 12-month revenue of around CAD$435,460. All prices are listed in Canadian Dollars.

  • Market capitalization: $210,823,424

Back to top

Compare trading platforms

Compare online trading platforms by fees, asset types and bonuses to find the best for your investment in psychedelic stocks.
Name Product Stock trade fee Asset types Minimum deposit to open Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
$1
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Public
$0
Stocks, ETFs
$0
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Webull
$0
Stocks, Options, ETFs
$0
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
TD Ameritrade
$0
or $25 broker-assisted
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0
TD Ameritrade features $0 commission for online stock trades. Online options fees are $0.65/contract.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Bottom line

While it’s possible to turn a profit investing in psychedelic stocks, keep in mind that — like any investment — psychedelic stocks are not immune to risk. These stocks are subject to fluctuating conditions — both in the market and in the experimental drug industry, so carefully vet your picks before you invest. And if you’re new to investing, or if it’s been awhile since you’ve taken a critical look at your investing accounts, compare brokers to make sure you’re getting the best features in your trading account.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site